SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-18-296982
Filing Date
2018-10-10
Accepted
2018-10-10 19:17:38
Documents
2
Effectiveness Date
2018-10-10

Document Format Files

Seq Description Document Type Size
1 FORM S-1MEF d615479ds1mef.htm S-1MEF 41933
2 EX-23.1 d615479dex231.htm EX-23.1 1842
  Complete submission text file 0001193125-18-296982.txt   44793
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-227774 | Film No.: 181117030
SIC: 2836 Biological Products, (No Diagnostic Substances)